Family Medicine pp 1005-1012 | Cite as

Skin Tumors

  • Michael Herbst
  • Denise K. C. Sur
  • Allen S. Yang
Chapter

Abstract

Skin tumors are very common, often dangerous, and sometimes disfiguring. Family physicians are particularly well equipped to prevent, diagnose, treat, and follow skin tumors. For example, advising patients to limit their recreational and occupational sun exposure can prevent skin cancers. Knowledge of patients’ risk factors for skin tumors and performing screening skin examinations permits early diagnosis. The procedural skills of family physicians are effective for treatment of most skin tumors. Continuity of care provides the ideal setting for follow-up of these tumors and prevention of their sequelae.

Keywords

Skin Cancer Basal Cell Carcinoma Skin Tumor Cavernous Hemangioma Nonmelanoma Skin Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Esterly NB. Cutaneous hemangiomas, vascular stains, malformations, and associated syndromes. Curr Probl Dermatol 1995; 3: 69–107.CrossRefGoogle Scholar
  2. 2.
    Bowers RE, Graham EA, Tomlinson KM. The natural history of the strawberry nevus. Arch Dermatol 1960; 62: 667–80.CrossRefGoogle Scholar
  3. 3.
    Dohil MA. Vascular and pigmented birthmarks. Pediatr Clin North Am 2000;47(4):783–812, v-vi.Google Scholar
  4. 4.
    Akyuz C, Yaris N, Kutluk MT, Buyukpamukcu M. Management of cutaneous hemangiomas: a retrospective analysis of 1109 cases and comparison of conventional dose prednisolone with high-dose methylprednisolone therapy. Pediatr Hematol Oncol 2001; 18 (1): 47–55.PubMedCrossRefGoogle Scholar
  5. 5.
    Beacham BE. Solar-induced epidermal tumors in the elderly. Am Fam Physician 1990; 42: 153–60.PubMedGoogle Scholar
  6. 6.
    Thomas JM. Premalignant and malignant epithelial tumors. In: Sams WM Jr, Lynch PJ, eds. Principles and practice of dermatology. New York: Churchill Livingstone, 1990; 199–213.Google Scholar
  7. 7.
    Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42 (1 pt 2): 23–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Marks R. The role of treatment of actinic keratoses in the prevention of morbidity and mortality due to squamous cell carcinoma. Arch Dermatol 1991; 127: 1031–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Yeatts D, Burns JC. Common oral mucosal lesions in adults. Am Fam Physician 1991; 44: 2043–50.PubMedGoogle Scholar
  10. 10.
    Triantos D, Porter SR, Scully C, Teo CG. Oral hairy leukoplakia: clinicopathologic features, pathogenesis, diagnosis, and clinical significance. Clin Infect Dis 1997; 25 (6): 1392–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Lee M, Wick MM. Bowen’s disease. CA Cancer J Clin 1990; 40: 237–42.PubMedCrossRefGoogle Scholar
  12. 12.
    Fitzpatrick TB, Johnson RA, Wolff K, Suurmond D. Color atlas and synopsis of clinical dermatology. New York: McGraw-Hill, 2000.Google Scholar
  13. 13.
    Rhodes AR. Public education and cancer of the skin: what do people need to know about melanoma and non-melanoma skin cancer? Cancer 1995; 75 (suppl): 613–36.PubMedCrossRefGoogle Scholar
  14. 14.
    Borenza SJ, Waterman G, Fenske NA. Malignant melanoma: management guidelines. Geriatrics 1990; 45: 55–62.Google Scholar
  15. 15.
    Goldstein AM, Tucker MA. Etiology, epidemiology, risk factors, and public health issues of melanoma. Curr Opin Oncol 1993; 5: 358–63.PubMedCrossRefGoogle Scholar
  16. 16.
    Bruce AJ, Brodland DG. Overview of skin cancer detection and prevention for the primary care physician. Mayo Clin Proc 2000; 75: 491–500.PubMedGoogle Scholar
  17. 17.
    Mora R. Non-melanoma skin cancer. Prim Care 1989; 16: 66584.Google Scholar
  18. 18.
    Marcil I, Stern RS. Risk of developing a subsequent non-melanoma skin cancer in patients with a history of non-melanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000; 136 (12): 1524–30.PubMedCrossRefGoogle Scholar
  19. 19.
    Friedman RJ, Rigel DS, Silverman MK, Kopf AW, Vossaert KA. Malignant melanoma in the 1990’s: the continued importance of early detection and the role of physician examination and self-examination of the skin. CA Cancer J Clin 1991; 41: 201–26.PubMedCrossRefGoogle Scholar
  20. 20.
    Jerant AF, Johnson JT, Sheridan CD, Cafrey TJ. Early detection and treatment of skin cancer. Am Fam Physician 2000; 357–68.Google Scholar
  21. 21.
    Roth ME, Grant-Kels JM. Important melanocytic lesions in childhood and adolescence. Pediatr Clin North Am 1991; 38: 791–809.PubMedGoogle Scholar
  22. 22.
    Safai B, Diaz B, Schwartz J. Malignant neoplasms associated with the human immunodeficiency virus infection. CA Cancer J Clin 1992; 42: 74–95.PubMedCrossRefGoogle Scholar
  23. 23.
    Prieto VG, Shea CR. Update on dermatopathology: selected cutaneous vascular neoplasms. Dermatol Clin 1999; 17: 507–20.PubMedCrossRefGoogle Scholar
  24. 24.
    Gascon P, Schwartz RA. Kaposi’s sarcoma: new treatment modalities. Dermatol Clin 2000; 18: 169–75.PubMedCrossRefGoogle Scholar
  25. 25.
    Thakur N. Topical ointments and wound healing. J Fam Pract 1997; 44 (1): 26–7.PubMedGoogle Scholar
  26. 26.
    Cho CY, Lo JS. Dressing the part. Dermatol Clin 1998; 16 (1): 25–47.PubMedCrossRefGoogle Scholar
  27. 27.
    Smack DP, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs. bacitracin ointment. JAMA 1996; 276 (12): 972–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Michael Herbst
  • Denise K. C. Sur
  • Allen S. Yang

There are no affiliations available

Personalised recommendations